CYTK stock quote, chart and news. Get Cytokinetics, Inc.'s stock price today. CYTK Stock Price, Forecast & News (Cytokinetics) | MarketBeat Cytokinetics' stock was trading at $12.03 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CYTK stock has increased by 0.2% and is now trading at $12.05. View which stocks have … Cytokinetics, Incorporated (CYTK) Stock Price, Quote ... Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. Cytokinetics, Incorporated Common Stock (CYTK) Stock ... Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Cytokinetics... (CYTK) Stock Quote | Price Chart | Volume ...
Real time Cytokinetics (CYTK) stock price quote, stock graph, news & analysis. Cytokinetics Inc Stock Quote: CYTK Stock News, Quotes ... Nov 06, 2019 · CYTK, Cytokinetics Inc - Stock quote performance, technical chart analysis, Cytokinetics Inc (CYTK) - DEVELOPS SMALL MOLECULE DRUGS THAT MODULATE MUSCLE FUNCTION IN PATIENTS WITH DISEASES OR MEDICAL CONDITIONS. GROUP LEADERSHIP TODAY… CYTK Stock Price Quote & News - Cytokinetics | Robinhood View the real-time CYTK price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cytokinetics against related stocks people have also bought like PLUG, VKTX, ACB, and CRON. 1,288 people own Cytokinetics on Robinhood on April 3, 2020. Cytokinetics, Incorporated (CYTK) Stock Forum & Discussion ... Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Stock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Dan Fitzpatrick. Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Stock Movers: Why Cytokinetics, Incorporated (CYTK) Stock ... Jan 31, 2020 · This means the stock has a potential increase of 78.06% from where the CYTK share price has been trading recently. During the recent trading session for Cytokinetics, Incorporated (NASDAQ:CYTK), the company witnessed their stock rise $0.38 over a week and surge $1.84 from the price 20 days ago. CYTK Stock News - Fidelity
CYTK:NASDAQ GS Stock Quote - Cytokinetics Inc - Bloomberg ...
Real time Cytokinetics (CYTK) stock price quote, stock graph, news & analysis. View Cytokinetics, Incorporated CYTK investment & stock information. Get the latest Cytokinetics, Incorporated CYTK detailed stock quotes, stock data, What is Cytokinetics' stock price today? One share of CYTK stock can currently be purchased for approximately $12.41. How big of a company is Cytokinetics?
1 Year % Chg 40.46. Market Cap 722.4M. Shares Outstanding 59.5M. Beta 1.18. Dividend (Yield) -. Div Amount -. Ex Div Date -. Earnings Date 2020-05-07.
Cytokinetics, Incorporated Common Stock (CYTK) Historical ... Find the latest historical data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics Stock Price History + Charts (CYTK) • Dogs of ... The following presents a detailed Cytokinetics stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Cytokinetics stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen). CYTK | Cytokinetics Inc. Stock Price & News - WSJ
CYTK - Cytokinetics Stock Price - Barchart.com Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Price/Book: A financial ratio used to compare a company's current market price to its book value. Price/Earnings: Latest closing price divided by the earnings-per-share based on the trailing 12 months. Companies with negative earnings receive an "NE."